Oncology Institute, Inc.

The Oncology Institute, Inc. (Nasdaq: TOI) is a value-based, community-focused oncology services company that reached the public markets through a SPAC business combination with DFB Healthcare Acquisitions Corp., a blank-check vehicle sponsored by DFB Healthcare Holdings, LLC that completed its initial public offering in 2020. Targeting the healthcare and oncology services sector, the SPAC pursued a partner with a community-based care model, and the de-SPAC transaction with The Oncology Institute closed in 2021. The November 2020 Form 10-Q, filed under accession 0001104659-20-125040, captures the company's reporting during the pre-combination search phase. For full filing histories, deal timelines, sponsor details, and analytics across the SPAC universe, sign up for complete access at SpacDesk.